BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16942547)

  • 1. Patient information on cognitive symptoms in multiple sclerosis - acceptability in relation to disease duration.
    Heesen C; Segal J; Reich C; Hämäläinen P; Broemel F; Niemann S; Simon U; Gross R; Kasper J
    Acta Neurol Scand; 2006 Oct; 114(4):268-72. PubMed ID: 16942547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspected multiple sclerosis - what to do? Evaluation of a patient information leaflet.
    Heesen C; Schäffler N; Kasper J; Mühlhauser I; Köpke S
    Mult Scler; 2009 Sep; 15(9):1103-12. PubMed ID: 19625332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cognitive impairment].
    Reuter F; Audoin B; Rico A; Malikova I; Ranjeva JP; Pelletier J
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S113-22. PubMed ID: 19361675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Communication of the diagnosis of multiple sclerosis: the patient's opinion].
    López LG; Tello CR
    Neurologia; 2008; 23(6):367-72. PubMed ID: 18597191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cognitive burden of multiple sclerosis in children.
    Banwell BL; Anderson PE
    Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized group intervention trial to enhance mood and self-efficacy in people with multiple sclerosis.
    Rigby SA; Thornton EW; Young CA
    Br J Health Psychol; 2008 Nov; 13(Pt 4):619-31. PubMed ID: 17845738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
    Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B
    Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of a cognitive intervention program for persons with multiple sclerosis.
    Shevil E; Finlayson M
    Health Educ Res; 2010 Feb; 25(1):41-53. PubMed ID: 19651639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive dysfunction as a hidden multiple sclerosis related symptom relevant for an expert appraisal].
    Kraus J; Lohmann H; Evers S
    Fortschr Neurol Psychiatr; 2009 Jan; 77(1):38-43. PubMed ID: 19101878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Depression in multiple sclerosis].
    Lebrun C; Cohen M
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S156-62. PubMed ID: 19361681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpreting patient/informant discrepancies of reported cognitive symptoms in MS.
    Carone DA; Benedict RH; Munschauer FE; Fishman I; Weinstock-Guttman B
    J Int Neuropsychol Soc; 2005 Sep; 11(5):574-83. PubMed ID: 16212684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis.
    Kalmar JH; Gaudino EA; Moore NB; Halper J; Deluca J
    Neuropsychology; 2008 Jul; 22(4):442-9. PubMed ID: 18590356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care.
    Solari A; Martinelli V; Trojano M; Lugaresi A; Granella F; Giordano A; Messmer Uccelli M; D'Alessandro R; Pucci E; Confalonieri P; Borreani C;
    Mult Scler; 2010 Nov; 16(11):1393-405. PubMed ID: 20858692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
    Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The possibilities of neuropsychological rehabilitation in multiple sclerosis].
    Rosti-Otajärvi E; Hämäläinen P
    Duodecim; 2010; 126(24):2845-52. PubMed ID: 21268907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Ghaffar O; Feinstein A
    Neurology; 2008 Jul; 71(3):164-9. PubMed ID: 18272863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.